Psoriasis is a chronic autoinflammatory skin disease associated with multiple comorbidities,
with a prevalence ranging from 2 to 3% in the general population. Decades of preclinical …

Background Psoriasis is a debilitating chronic inflammatory autoimmune disease affecting
approximately 7.4 million adults in the United States. Plaque psoriasis is the most common …

Background Patients with psoriasis value rapid and complete skin clearance. No head‐to‐
head studies have focused on early responses to interleukin (IL)‐17 vs. IL‐23 inhibitors …

Background Psoriasis is a chronic disease requiring long‐term therapy. Objectives
Physician‐and patient‐reported outcomes were evaluated through week 252 in VOYAGE 1 …

Background Though patient needs are key drivers of treatment decisions, they are rarely
systematically investigated in routine care. Objective This study aimed at analysing needs …

The burden of visible skin diseases (VSDs) includes not only physical symptoms but also
psychosocial consequences such as depression, anxiety, impaired quality of life and low …

Psoriasis is an inflammatory noncommunicable skin disease that affects both adults and
children. At present, the epidemiology and natural history of psoriasis are not widely …

Atopic dermatitis (AD) is a chronic, auto‐immune condition that imposes a high burden on
individuals, society, and the healthcare system. Approximately 4.4% of adults and up to …

Background Psoriasis affects 0.13%-2.1% of children and adolescents. Despite a high
unmet need, the current treatment options approved for pediatric psoriasis are limited …

In times of targeted therapies, innovative therapeutics become tools to further unravel the
pathogenesis of the treated disease, thus influencing current pathogenetic concepts. Based …